Ninety One North America’s Dentsply Sirona XRAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-40,094
Closed -$1.97M 103
2022
Q1
$1.97M Sell
40,094
-141,714
-78% -$7.49M 0.07% 97
2021
Q4
$10.1M Buy
181,808
+20,180
+12% +$1.11M 0.35% 50
2021
Q3
$9.38M Buy
161,628
+32,349
+25% +$1.99M 0.43% 46
2021
Q2
$8.18M Sell
129,279
-28,786
-18% -$1.9M 0.38% 52
2021
Q1
$10.1M Sell
158,065
-4,049
-2% -$235K 0.58% 46
2020
Q4
$8.49M Buy
162,114
+109,263
+207% +$5.39M 0.52% 50
2020
Q3
$2.31M Buy
52,851
+13,436
+34% +$594K 0.25% 82
2020
Q2
$1.74M Buy
+39,415
New +$1.67M 0.18% 88

Other funds holding XRAY

Ninety One North America's XRAY Position: Q2 2022 in Review

Ninety One North America sold out of Dentsply Sirona (XRAY) in Q2 2022, closing a stake of 40,094 shares — an estimated $1.97M sold.

Ninety One North America first reported a position in XRAY in Q2 2020 and held it in 8 quarters. The position peaked at $10.1M in Q4 2021. 470 funds tracked by Wall St. Rank hold XRAY as of Q2 2022.

  • Ninety One North America reported no remaining Dentsply Sirona position as of Q2 2022 after selling out during the quarter.
  • Ninety One North America sold 40,094 Dentsply Sirona shares in Q2 2022, an estimated $1.97M.
  • Ninety One North America first reported a position in Dentsply Sirona in Q2 2020 and held it in 8 quarters.
  • Ninety One North America's Dentsply Sirona position peaked at $10.1M in Q4 2021.
  • 470 funds tracked by Wall St. Rank held Dentsply Sirona as of Q2 2022.

Based on Ninety One North America's 13F filing for Q2 2022, filed 15 Aug 2022.